Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Live Francisella Tularensis Vaccine NDBR 101
NCT00584844Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Oct 2004
- Primary completion
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NDBR 101 in tularemia, sponsored by U.S. Army Medical Research and Development Command. Started Oct 2004; status: completed.
02
Drugs
NDBR 101
03
Conditions
tularemia
Beyond the preview
Go deeper on NCT00584844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584844.